GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on the health of billions of patients globally. Our Ahead Together strategy is centred on early intervention to prevent and alter the course of disease, thereby protecting people and supporting healthcare systems.
Our diverse portfolio consists of vaccines, specialty medicines, and general medicines.
Through continuous innovation and a dedicated focus on scientific and technical excellence, we strive to develop and launch new, groundbreaking treatments that address critical health challenges.
Lead complex M&A; carve-out, separation, integration and transformation programmes across multiple functions, translating strategic objectives into clear, measurable outcomes and sustainable business value. Provide end-to-end leadership across pre-deal, sign-to-close and post-close phases, ensuring operational readiness, business continuity,
effective execution and delivery of deal value.
Establish integrated transformation plans, governance, priorities and milestones, aligning senior stakeholders around critical value drivers and enabling disciplined decisions on technology, investment and resource allocation. Identify and proactively manage execution risks, dependencies and opportunities across the programme.
Build an agile, collaborative and innovation-led setting that enables teams to navigate ambiguity, adapt rapidly and deliver at pace. Partner with cross-functional leaders to embed new operating models, realise synergies, drive sustainable performance improvements and ensure transformation outcomes are fully integrated into the business.
Lead proactive stakeholder engagement and communications, ensuring clear, timely and consistent messaging on programme objectives, progress, risks, decisions and business impacts.
Key Responsibilities
📌 Associate Director (Bengaluru)
🏢 GSK
📍 Bengaluru